TECH Signal 481
Kinney Drugs pulls back AI phone assistant after hundreds of customer complaints
↗
Kinney Drugs is reverting inbound patient calls to a touch-tone system after its AI phone assistant produced incoherent calls, wrong dosages, and missed prescription notifications.
This is a clear case of AI deployment failing in a healthcare context where errors carry patient safety risks, not just UX friction. The rollback demonstrates that compliance with privacy regulations does not guarantee safe or accurate information delivery.
Written by elseif from the cluster below · every claim links back to a sourceThe three things worth knowing
Kinney Drugs introduced an AI assistant named Burt in May to handle prescription communications, but is now reverting inbound calls to a touch-tone phone system after hundreds of customer complaints.
Customers reported incoherent calls, wrong dosages communicated to them, and missed prescription notifications, errors with direct patient safety implications.
The company will retain Burt for outbound prescription refill texts on an opt-in basis, suggesting the technology works for simpler one-directional communication but fails on variable inbound inquiries.
THE CLUSTER